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Phytochemicals in Rosmarinus officinalis leaves, their total phenolic content, antioxidant potential 
and antiproliferative activity against human prostate (DU145), colon (CT26) and cervical (HeLa 229) 
cancer cells were investigated. Extraction was done separately using hexane, dichloromethane, ethyl 
acetate and methanol. A total of 32 compounds were identified, eight of which were reported for the 
first time. The highest phenolic content was 476.80 ± 0.69 µg/ml for the methanolic extract which 
also had the highest antioxidant activity with a minimum inhibitory concentration of 5.39 ± 0.09 
mg/ml. Extracts exhibited the highest toxicity against prostate cancer cells and the least against 
cervical cancer cells. 
________________________________________________________________________________ 
Introduction 
Cancer is one of the leading causes of 
mortality worldwide [1]. It is characterized by 
irregular proliferation of malignant cells in a 
series of stages with different biochemical, 
molecular and cellular events [2]. Cancer is 
caused by both internal factors (such as 
mutations, hormones and immune conditions) 
and external factors like chemicals, radiation and 
infectious microorganisms [3, 4]. 
Treatment of cancer is costly, and this has 
been exacerbated by the resistance of tumor cells 
to the available antineoplastic drugs. Due to their 
lack of specificity, the conventional cancer 
therapies present severe side effects and in most 
developing countries are inaccessible to cancer 
patients [5]. Thus, traditional medicine is gaining 
more attention in chemoprotective management 
of cancer [1]. Over 3,000 plant species have been 
reported to have anticancer properties [6]. An 
example is Camptotheca acuminate from which 
the anticancer drug Camptothecin has been 
developed [6].  
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Although a number of plants have been claimed 
to have antitumor properties, they have not been 
fully investigated for the development of novel 
anticancer drugs [7]. Rosmarinus officinalis L. 
(Rosemary) is one of the plants used in the 
traditional management of cancer in Uganda. 
However, its safety to humans as well as 
identification and isolation of the main phenolic 
compounds as the presupposed source of 
anticancer activity has not been fully 
documented. In the current study, we report on 
the phytochemicals in the leaves of R. officinalis, 
their total phenolic content, antioxidant potential 
and antiproliferative activity against human 
prostate (DU145), colon (CT26) and cervical 
(HeLa 229) cancer cells.  
Experimental part 
Ethical approval  
        This study was approved by Centre for 
Traditional Medicine and Drug Research, Kenya 
Medical Research Institute Scientific and Ethics 
Review Unit, Kenya (Approval No. 
KEMRI/RES/7/3/1). 
 
Sampling and sample preparation   
Leaves of R. officinalis were collected from 
cultivated plants in Wakiso district of Uganda 
(0023’36” N, 3300’9” E) with permission from 
Uganda Natural Chemotherapeutics Research 
Institute, Kampala, Uganda where they were 
identified by Kyoshabire Medius (a taxonomist). 
A voucher sample (No. 50907) was deposited at 
Makerere University Herbarium, Kampala, 
Uganda on 7th August 2019.  
Laboratory samples were air-dried in mesh bags 
and ground into a fine powder using a laboratory 
mill. Weighed 150 ± 0.1 g of the powder were 
separately extracted with 775 ml of n-hexane, 
dichloromethane (DCM), ethyl acetate and 
methanol in 1000 ml conical flasks for 96 hours 
at room temperature. The crude extracts were 
filtered using a cheese cloth, Whatman No. 1 
filter paper and concentrated to dryness on a 
rotary evaporator (Rotavapor BUCHIR-100, 
Switzerland) [8]. The extracts were transferred 
into sample bottles which were placed in a 
desiccator of anhydrous sodium sulphate. The 
yields of the extracts were calculated (Equation 
1) and they were transferred into tightly 
stoppered bottles which were kept at 4 ℃.  
Percentage yield = ×  100          (1) 
Where A is the amount of crude extract obtained 
after drying and A0 is the weight of the leaves 
used for extraction. 
Fractionation was done for the methanol extract 
because it had the highest yield. The dried crude 
methanol extract was divided into two parts; one 
portion (1.5 g) was kept in the crude form and the 
other portion (8 g) was subjected to column 
chromatography fractionation.  
Antiproliferative activity of the extracts 
The Vero, prostate (DU145), colorectal (CT26) 
and cervical (HeLa 229) cancer cells were 
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separately thawed in a water bath at 37 0C. 
Growth media (20 ml) was added to 1 ml of each 
of the cell lines in T-75 culture flasks and 
incubated at 5% carbon dioxide and 37 0C to 
revive the cells. Culturing was done for three 
days until when the cells obtained at least 80% 
confluence. The excess media was poured off, 
leaving the cells attached to the surface of the 
flask and the flask was washed 3 times with 
phosphate buffer saline (PBS). Excess PBS was 
poured off and then 500 µL of Trypsin-EDTA 
was added into the flask having cells attached to 
the surface. This was spread evenly on the inner 
surface of the flask by tilting the flask back and 
forth and then incubating for 3 minutes. Trypsin 
was added to detach the cells off the surface of 
the flask. Growth media (10 ml) was added 
immediately to stop the action of Trypsin. 
Growth media was purged gently to allow 
breaking of clumps between cells. 
In vitro antiproliferative assay was done for both 
crude extracts and the solid phase extracted 
methanolic isolates using MTT assay [9]. 
Briefly, the cancer cells were washed 3 times 
with 5 ml of PBS after attainment of 100% 
confluence and harvested by trypsinization. The 
number of viable cells was determined by Trypan 
blue exclusion test. Approximately 2 × 104 
cells/ml suspension of both Vero and cancer cells 
were seeded in 96-well plates and incubated for 
24 hours.  
Measured 15 μl of the extracts and the 
commercial drug doxorubicin at seven different 
concentrations (1000, 333.33, 111.11, 37.03, 
12.34, 4.11 and 1.37 µg/ml) were added from 
rows H to B and the plates incubated for 48 
hours. Row A acted as the negative control 
(extracts or the drug were not added to it).  
After incubation, 10 µl of MTT dye solution was 
added to each of the wells in the plates and 
incubated for 4 hours. The media was then 
poured off from the wells of the plates leaving 
cells alone attached to the surface. Measured 50 
µl of DMSO was added to solubilize the 
formazan crystal formed by viable cells. 
Absorbance was then read on a scanning multi-
well spectrophotometer at 562 nm [10].  
Absorbance values higher than the control cells 
indicated an increase in the rate of cell 
proliferation and vice versa [11]. The percentage 
viability was evaluated by determining 
absorbance with the corresponding chemical 
concentrations. Linear regression analysis at 
95% confidence limits and R2 were used to 
define dose-response curves of percentage 
viability of cells against concentration. 
Percentage of cell viability was calculated using 
Equation 2 and Equation 3. 
% cell viability = 100 - % cytotoxicity     (2) 
% cytotoxicity =  ×  100                     (3)      
Where A is the optical density of control and B 
is optical density of test drug. 
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Data was analyzed to obtain the minimum 
inhibitory concentration (IC50) and median 
cytotoxic concentration (CC50) of the extracts on 
cancer and Vero cells, respectively [12]. The 
selectivity index (SI) was calculated as the ratio 
of CC50 to IC50 [7, 13]. 
Determination of total phenolic content and 
antioxidant activity 
The TPC of the extracts were determined using 
Folin-Ciocalteu reagent as described by previous 
authors [14, 15]. Briefly, 0.5 ml of the extract 
dissolved in 1 mg/L of methanol in falcon tubes. 
Gallic acid solutions of 0, 20, 40, 80 and 100 
µg/ml were also added into the tubes in methanol 
: water (50 : 50 v/v) were mixed with 0.5 ml of 
Folin-Ciocalteu reagent diluted 10-fold in 
distilled water in falcon tubes and allowed to 
stand at room temperature for 5 minutes. Exactly 
1.5 ml of sodium carbonate (20 g in 100 ml of 
distilled water) solution was then added, 
followed by 8.5 ml of distilled water. After 90 
minutes, the absorbance was measured using 
UV-1900 UV Vis Spectrophotometer (Shimadzu 
Corporation, Japan) at 755 nm using Gallic acid 
as the standard solution [16]. 
Antioxidant activity was assessed using DPPH 
radical scavenging assay as described by Awah 
and Verla [14]. Briefly, 8.5 ml of methanol was 
added to 0.1 g of the extracts. From these, 200 
µg/ml was made by transferring 0.167 ml of 
sample stock solutions in different falcon tubes 
and the volume made up to 10 ml. The solutions 
were then mixed with 1 ml of 0.1 mM DPPH in 
methanol. The mixture was shaken vigorously 
and allowed to stand at room temperature in the 
dark for 25 minutes. Blank solutions were 
prepared with 1 ml of methanol while the 
negative control was 1 ml of 0.1mM DPPH 
solution in 2 ml of methanol. Thereafter, the 
absorbance of the assay mixtures was measured 
at 517 nm using a UV visible spectrophotometer 
to measure the decolourization to yellow 
diphenylpicrylhydrazine. DPPH radical 
inhibition was calculated using Equation 4. 
% inhibition = (
  
)  × 100      (4) 
Where 𝐴  = the average absorbance of blank 
(untreated cells) and 𝐴  = absorbance of the 
sample (treated cells). 
Characterization of compounds in R. officinalis 
methanolic leaf extract 
The functional groups in the extract fractions 
were analyzed by Fourier Transform Infrared 
Spectroscopy (FTIR) using a Shimadzu FTIR 
spectrometer (Nicolet NEXUS 470, Thermo 
Scientific, USA). Aliquots (0.1 g) of the fractions 
were dissolved in 10 ml of methanol. Exactly 0.6 
ml of the sample solution was poured on 
Attenuated Total Reflection (ATR) crystal and 
the spectra were read at 4500 to 400 cm-1. The 
frequencies of the different components were 
recorded. The resolution was 4 cm-1 for 20 scans 
on each sample [17, 18]. The analysis was 
repeated twice for spectra confirmation. 
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Solid phase extraction and clean up was done for 
the methanol and ethyl acetate fractions. The 
end-capped C18 cartridge of sorbent mass, 500 
mg; particle size, 50 µm; pore diameter, 48Å; 
surface area, 526 m2/g was conditioned with 5 ml 
of 10% methanol in acidified water. Measured 20 
ml of each fraction solution was loaded into a C-
18 (Supelco, Sigma-Aldrich Germany) column 
and allowed to flow under gravity. The co-
extracted substances were eluted from the 
sorbent with 100 ml of aqueous acetic acid (2% 
v/v). The column was dried using a pressure 
pump in the vacuum manifold for 5 minutes and 
total retained phenols were eluted with 1.2 ml of 
0.1% formic acid acidified methanol [19]. 
Purified extracts were filtered through a 0.1 μm 
filter prior to liquid chromatography-mass 
spectrometry/mass spectrometry (LC-MS/MS) 
analyses [20]. 
LC-MS/MS was used to identify compounds in 
the clean-up fractions. The auto-sampler LC 
system (Finnigan, Thermo Electron Corporation, 
USA) was coupled to an MS detector (Agilent 
Technologies, 6420 Triple Quad, USA). Sample 
solutions of 5 μL were injected into C-18 reverse 
phase column (Poroshell 120 EC-C18 3 × 50 
mm, 2.7 µm, USA) at 40 °C. Data acquisition 
software was for 6400 Series Triple Quadrupole 
(Version B.08.00, Qualitative analysis software 
Version B.07.00 Service Pack 1). Solvent A was 
made of a mixture of 0.1% formic acid in water 
and 0.1% ammonium formate in water. It was 
made by adding 1 ml of formic acid to 1000 ml 
of water and then a solution of 1.0 g of 
ammonium formate dissolved in 1000 ml of 
deionized water and the two solutions were 
mixed to form solvent A. Solvent B was made of 
0.1% formic acid in methanol which was made 
by adding 0.6 ml formic acid to 600 ml of 
methanol.  
The elution was conducted at a column flow rate 
of 0.5 ml/min, the pressure of 350 bars, a column 
temperature of 40 0C at gradient elution for 35 
minutes [21]. From 0 to 0.5 minutes, elution was 
95% solvent A and 5% solvent B, 0.5-12 minutes 
was 58% A and 42% B, at 12-15 minutes was 
40% A and 60% B, 15-20 minutes was 5% A and 
95% B, 20-25 minutes was 5% A and 95% B, 25-
25.5 minutes was 90% A and 10% B and then 25-
35 min was 95% A and 5% B. The eluent was 
monitored at Electron spray ionization connected 
to an ion trap MS (ESI-MS) under negative ion 
mode at full scan mode of 55-500 m/z [22]. 
Identification of the compounds was based on 
retention time in reversed-phase LC and MS 
spectral features [21]. 
Statistical analysis 
Experiments were done in triplicate and data 
presented as means ± standard deviations. 
ANOVA was used to establish any significant 
differences between extracts and controls. 
Correlations between antioxidant activity and 
antiproliferative activity were established using 
Pearson’s correlation coefficient. Analyses were 
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performed at P < 0.05 using Minitab statistical 
software (Release 17, Minitab Inc., USA).  
Results and discussion 
Percentage yield 
The yield of the different extracts, obtained as the 
percentages of initial mass of the sample 
macerated is shown in Table 1.  
Table 1. Organic extract yield of R. officinalis leaves 
Solvent Yield (g)  Percentage yield 
Methanol 81.210 54.14 
Ethyl acetate 65.115 43.41 
Dichloromethane 58.005 38.67 
Hexane 32.025 21.35 
 
Methanol gave the highest yield (54.14%) while 
n-hexane gave the least yield (21.35%). This is 
could be due to the differences in polarity as 
methanol being the most polar gave the highest 
yield. It could be because it extracted many 
compounds from the leaves. Differences in 
solvent polarities used for extraction is known to 
play a key role in increasing the solubility of 
phytochemical compounds [23, 24]. Further, 
differences in the structure of phytochemical 
compounds also determine their solubility in 
solvents of different polarities [25]. Indeed, the 
four solvents used had different polarities 
arranged as hexane < DCM < ethyl acetate < 
methanol. Therefore, the results of the current 
study confirmed the effect of varying solvent 
polarities on the yield of plant extracts and 
confirmed the richness of R. officinalis leaves in 
polar phytochemicals. The results obtained are 
consistent with those of Widyawati et al. [26] 
who assessed the effects of solvent polarity on 
the phytochemical yields from Pluchea indicia 
leaf extracts.  
Antiproliferative activity of R. officinalis leaf 
extracts and fractions 
The anticancer activity was determined for both 
crude solvent extracts and fractionated methanol 
extract. The minimum inhibitory concentrations 
(µg/ml) required to give 50% of cell death (IC50) 
by the crude extracts and positive control 
(doxorubicin) on the prostate, colorectal and 
cervical cancer cells are shown in Table 2. 
Doxorubicin showed the highest activity on all 
cancer cell lines compared to the plant extracts 
(P ˂ 0.05). This was evidenced by its very low 
IC50 values (4.36 ± 0.22, 6.39 ± 0.47 and 3.64 ± 
0.33 µg/ml for prostate, colorectal and cervical 
cancer cell lines) compared to the plant extracts. 
Table 2. IC50 values (µg/ml) of R. officinalis leaf extracts 
against prostate, colorectal and cervical cancer cells 
Extract DU145 CT26 HeLa 229 
Methanol 147.38 ± 
0.53 
301.99 ± 0.53 432.47 ± 
0.41 
Ethyl acetate 182.48 ± 
0.50 
460.08 ± 0.14 522.80 ± 
1.06 
DCM 1459.10 ± 
0.86 
928.57 ± 0.49 931.63 ± 
1.19 




Doxorubicin 4.36 ± 0.22 6.39 ± 0.47 3.64 ± 0.33 
 
For results of antiproliferative activity, IC50 ˂ 10 
µg/ml is considered potentially very toxic; IC50 
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between 10 and 100 µg/ml is potentially toxic; 
IC50 between 100 and 1000 µg/ml is potentially 
harmful and IC50 ˃  1000 µg/ml is potentially non-
toxic [27]. As shown in Table 2, the methanol 
extracts were highly toxic on all the cancer cell 
lines studied compared to other extracts. This is 
because it showed the least IC50 values which 
means, only a small concentration of the extract 
is required to reduce the number of cancer cells 
by 50%. Ethyl acetate extract was the second 
most active, followed by DCM extracts and then 
finally hexane extracts. This order was also 
recorded for the TPCs as well as the antioxidant 
activity of the extracts. This shows that the 
phenols responsible for the antioxidant activity 
as well as cytotoxicity of these cancer cells are 
polar. Correlations between antioxidant activity 
of the crude extract and antiproliferative activity 
were established using Pearson’s correlation 
coefficient. It was found that the antioxidant 
activity is positively correlated with the 
antiproliferative activity of the crude extracts 
against cervical and colorectal cancer cell lines. 
However, there was a negative correlation for 
prostate cancer cell lines. The correlation was not 
statistically significant in all cancer cell lines (P 
˃ 0.05).  
Previous studies reported that R. officinalis 
extracts (6.25-50 µg/ml) inhibited viability of 
DU145 and PC3 prostate cancer cells with IC50 
of about 8.82 µg/ml [28]. The extracts were also 
effective against colon cancer cell lines: HT-29, 
HCT116, W480, and HGUE-C-1 for doses  
between 1.5 to 100 µg/ml  with IC50 between 16.2 
and 25 µg/ml [29-33]. For For HeLa (cervical 
adenocarcinoma), inhibition was at 1.56-400 
µg/ml with IC50 between 10.02 and 23.31 µg/ml 
[34, 35].  
The mechanism of anticancer activity of R. 
officinalis extracts is not clear though. Many 
studies attributed its antiproliferative activity to 
enhanced apoptosis and cell death [36]. Increased 
poly Adenosine diphosphate ribose polymerase 
(PARP) cleavage, an indicator of enhanced 
apoptosis was reported for colon, pancreas, 
breast and lung cancer cell lines [37]. Rosemary 
extract also increased nitric oxide production and 
tumor necrosis factor production in pancreatic 
and liver cancer cells [38, 39], indicating 
enhanced cell death capabilities and nitric oxide-
induced apoptosis. For ovarian cancer cells,  
enhanced apoptosis was associated with 
increased gene expression of mitochondrial-
regulated apoptosis proteins cytochrome c [40]. 
These proteins are in the electron transport chain, 
and along with heat shock protein 70 (hsp70) 
involved in protein folding protects the cell from 
heat stress and toxic chemicals. Other 
mechanisms of apoptosis by Rosemary extracts 
include enhanced protein expression of pro-
apoptotic Bax and cleaved-caspase 3 [32, 41], 
increased expression of binding immunoglobulin 
protein (BiP) and enhancer-binding protein 
homologous proteins (CHOP) which induce 
endoplasmic reticular stress [33, 41], and the 
unfolded protein response in prostate and colon 
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cancer cells [31, 33, 41, 42]. Rosemary extracts 
have also been reported to exert antioxidant 
effects in colon, breast and leukemia cell lines, 
protecting cells from oxidative DNA damage 
[37].  
The results of antiproliferative activity of the 
fractions from methanolic extract of R. officinalis 
leaves are shown in Table 3.  Ethyl acetate 
fraction showed the highest anticancer activity 
with IC50 of 6.39 ± 0.26, 261.31 ± 0.27 and 
119.34 ± 0.38 µg/ml for DU145, CT26 and HeLa 
229 cancer cells, respectively. On the other hand, 
hexane fraction had no activity against CT26 and 
HeLa 229 cells and had an IC50 of 1019.26 ± 0.28 
µg/ml for DU145 cells.  
Table 3. IC50 values (µg/ml) of the fractions of 
methanolic extract of R. officinalis on the cancer cells 
Fraction DU145 CT26 HeLa 229 








































3.64 ± 0.33 
SPE: solid phase extract. 
The CC50 of the extracts and the fractions were 
determined (Table 4).  
Table 4. CC50 values of the tested R. officinalis leaf 
extracts and fractions on Vero cells 
Extract/Fraction CC50 (µg/ml) 
Methanol extract 468.55 ±  0.51 
Ethyl acetate extract  599.27 ± 0.24 
DCM extract 1253.00 ± 0.62 
Hexane extract Not applicable  
Ethyl acetate fraction 401.09 ± 0.08 
Methanol fraction 378.38 ± 0.55 
DCM fraction 1644.64 ± 0.58 
Hexane fraction Not applicable 
Methanol SPE 1897.12 ± 0.11 
Ethyl acetate SPE 1841.27 ± 0.47 
Doxorubicin  6.36 ± 0.45 
The methanolic fraction of R. officinalis showed 
the least CC50 value of 378.38 µg/ml which is 
potentially harmful while the methanolic solid 
phase extract showed the highest CC50 value of 
1897.12 ± 0.11 µg/ml which is potentially non-
toxic. The results obtained showed that all the 
extracts under investigation were less toxic to 
normal Vero cells, compared to the positive 
control (doxorubicin) with CC50 = 6.36 ± 0.45 
µg/ml which is potentially very toxic. 
The fractions were comparatively more cytotoxic 
than the corresponding crude extracts while the 
solid phase extracts were less cytotoxic when 
compared to the crude extracts. This could be 
attributed to greater activity of the polyphenols 
than in crude extracts where they had 
interferences [43]. It was observed that the 
isolates obtained through solid phase extraction 
showed lower toxicity than the crude extracts and 
fractions. This could be due to synergistic effects 
in the crude extracts [30]. Among the fractions, 
ethyl acetate fraction showed better activity on 
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the cells than the methanol fraction. This could 
be due to the fact that ethyl acetate solvent was 
passed through the column before methanol and 
it had extracted most of the active compounds 
from the plant extracts. This was still carried on 
to the solid phase extracted isolates where it was 
observed that ethyl acetate isolates showed 
higher activity (p < 0.05). 
To further understand the cytotoxicity of the 
extracts when used for cancer therapy, the 
selectivity indices were calculated (Table 5). The 
selectivity index (SI) is the ability of an extract to 
inhibit the growth of cancer cells more than it 
does to the normal cells. An extract with the SI ˃ 
3 is considered to be highly selective and has the 
potential to be used in the management cancer 
[13]. Selectivity is the most important feature of 
an effective anticancer drug and a clear 
understanding of how much selectivity a new 
drug should have to be clinically effective is 
essential [13].  
Table 5. Selectivity indices of  R. officinalis leaf extracts 
and fractions  
Extract/fraction DU145 CT26 HeLa 229 
Methanolic extract 3.18 1.55 1.08 
Ethyl acetate extract 3.28 1.30 1.15 
DCM  extract     0.86 1.08 1.07 
Hexane  extract NA  NA  NA  
Methanolic fraction 14.18 1.47 1.04 
Ethyl acetate fraction 44.31 1.93 2.09 
DCM  fraction 2.02 2.13 2.89 
Hexane  fraction NA  NA  NA  
Methanolic  SPE 3.88 3.64 3.28 
Ethyl acetate SPE 4.29 3.60 3.34 
Doxorubicin 1.459 0.995 1.747 
 SPE: Solid phase extract, NA: Not applicable 
Solid phase extracted clean ups had the highest 
selectivity indices since they showed selectivity 
on all cells, followed by the ethyl acetate and 
methanolic fractions and then the crude extracts 
then the positive control (doxorubicin). The 
results showed that doxorubicin was not selective 
on Vero cells as its selectivity indices were quite 
lower than 3 [13]. Selective cytotoxicity is a 
pivotal requirement for anticancer drugs. 
Total phenolic content and antioxidant activity of 
the extracts 
The TPC of the extracts were determined using 
the Folin-Ciocalteau method. Folin-Ciocalteau 
reagent consists of a mixture of sodium 
molybdate, sodium tungstate and other reagents 
which when added to plant extracts react with 
phenolic compounds to produce a solution of a 
blue complex which absorbs at 760 nm. The 
assay relies on the transfer of electrons in 
alkaline medium from phenolic compounds to 
phosphomolybdic/phosphotungstic acid 
complexes [44, 45].  A calibration curve (Figure 
1) was prepared for the quantitative analysis and 
the linearity for gallic acid standard was 
established from the range of 1 µg/ml to 100 
µg/ml which was fitted on the line y = 0.0025x. 
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Figure 1. Calibration curve for TPC using Gallic acid 
standard. 
The methanol crude extract gave the highest TPC 
of 476.8 ± 0.69 µg/ml (Table 6). Methanol is a 
polar protic solvent [23, 46] and thus, it extracted 
more polyphenols which are inherently polar and 
their solubility is through hydrogen bond 
formation [47]. Further, ANOVA test showed 
that there were significant differences (p < 0.05) 
among the mean TPC of the different solvent 
extracts. From the results of the antioxidant 
activity assay (Figure 2), the IC50 of methanolic 
extract (5.39 ± 0.09 mg/ml) was the lowest as 
compared to 0.06 ± 0.01 mg/ml for ascorbic acid 
(control).  This is because most phenolic 
compounds responsible for antioxidant activity 
have polar functional groups which are easily 
dissolved in polar protic solvents like methanol 
[26]. The antioxidant activity of plant phenolic 
compounds is attributed to their redox properties 
which allow them to act as reducing agents, 
hydrogen donators, singlet oxygen quenchers 
and metal chelators [48]. The DPPH test 
measures the hydrogen atom or electron donating 
capacity of extracts to the stable radical DPPH 
formed in solution [49].  
Table 6. Total phenolic content of R. officinalis leaf 
extracts 
Extraction solvent  Total phenolic content 
(µg/ml GAE) 
Methanol 476.8 ± 0.69 
Ethyl acetate  74.80 ± 0.80 
Dichloromethane  37.47 ± 0.92 
n-hexane  21.33 ± 0.83 
 GAE: Gallic acid equivalent 
In a study which used R. officinalis from different 
regions of Algeria, Fellah et al. [50] reported 
TPC ranging from 58.26 ± 0.31 to 114.10 ± 0.15 
mg GAE/g dry weight.  
Figure 2. Antioxidant activity of R. officinalis leaf extracts 
Similarly, antioxidant activity with IC50 values of 
8.6 ± 0.5 to 19.4 ± 1.5 µg/ml was reported for R. 
officinalis leaf extracts by Garbarino et al. [51]. 
Further, Bourhia et al. [52] reported TPC of 
146.63, 92.39, 83.27 and 74.15 μg GAE/mg for 














































FRENCH-UKRAINIAN JOURNAL OF CHEMISTRY (2020, VOLUME 08, ISSUE 02)  
160 
 
Beni Mellal and Marrakesh regions of Algeria, 
respectively. The plants exhibited antioxidant 
activity with IC50 values of 0.302, 0.258, 0.236 
and 0.176 mg/ml, respectively.  
The antioxidant properties of rosemary have 
been attributed to its richness in isoprenoid 
quinones, which act as chain terminators of free 
radicals and as chelators of reactive oxygen 
species [53, 54]. Further, compounds such as 
rosmarinic acid and hesperidin found in 
rosemary extracts in this study have been cited in 
the literature as important free radical scavengers 
[55, 56]. 
Characterization of compounds in R. officinalis 
methanolic leaf extracts 
In the FT-IR spectrum (Figure 3), the intense 
absorption at 3400 cm-1 was due to stretching of 
phenolic groups present in the extracts. The band 
at 2900 cm-1 was due to stretching of hydroxyl 
groups like alcohols and water while the 
absorption at 2800 cm-1 could have been due to a 
C-H group stretching of sp3 hybridized (R3C-H) 
portion. Absorption at 1700 cm-1 is due to 
stretching of C=O group. The bend at 1550 cm-1 
is due to C=C bonds, typical of aromatic 
compounds (containing a benzene ring). 
Absorption at 1400 cm-1 was due to asymmetric 
in-plane bending of –CH3 while at 1350 cm-1, the 
absorption was due to symmetric in-plane 
bending of –CH3. The stretch at 1250 cm-1 is due 
to nitro groups (-NO2). The absorption at 1100 
cm-1 was due to C-O stretching vibration. The 
weak bands at 1000 cm-1 and 900 cm-1 could be 
due to C-H bending and terminal C=CH2 groups 
respectively. These assignments are based on 
previous studies on phenolic compounds in 
plants [17, 57, 58]. These confirmed the presence 
of phenolic compounds in the extract. The 
various functional groups observed in the 
extracts reflected the biochemical profile of the 
leaf extract which could be responsible for the 
various medicinal properties of this plant leaf, 
including antiproliferative activity. 
Phytochemicals such as phenolics, carotenoids, 
terpenoids and alkaloids from plants have been 
reported to be key actors in cancer therapy [1, 6, 
59]. 
Figure 3. FTIR spectrum of the methanolic fraction of R. 
officinalis leaf extract. 
LC-MS/MS qualitative analysis afforded the 
identification of 32 compounds in R. officinalis 
methanolic leaf extract (Table 8). These 
compounds included polyphenols (such as gallic 
acid, rosmanol, rosmarinic acid), flavonoids, 
terpenoids and alkaloids. The standards used for 
quality control in the study (gallic acid and rutin) 
showed similar LC chromatograms and MS 
spectra with their corresponding compounds in 
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the samples. Of the 32 compounds identified, 
were eight compounds reported for the first time 
in this plant. These are procyanidin, 
hydroxyplorentin, cephalin, isoquercetin, 
latifoliamide, diadzin, hyperin and emetine 
(Figure 4). Mena et al. [60] reported the presence 
of (poly)phenolic compounds in R. Officinalis 
leaves. Using ultra-high-performance liquid 
chromatography-electrospray ionization-mass 
spectrometry afforded the identification and 
quantification of 57 compounds, 14 of  which 
were reported for the first time.  
 
 
Table 8. Compounds identified in R. officinalis leaf extract 
Peak Rt (s) m/z MF Fragments (CE) Compound 
1 2.060 191.1 C7H12O6 127.0 (24), 93.0 (32) Quinic acid  
2 2.967 163.1 C7H8O2 117.1 (40) Anustoline 
3 3.082 179 C9H8O4 135 (10), 134 (20) Caffeic acid 
4 3.128 235.2 C27H30O16 86.1 (16), 58.2 (36) Rutin 
5 8.306 220.1 C30H26O13 56.1 (52) Procyanidin 
6 8.466 304.2 C15H15O6 182.1(16), 82(48) Hydroxyphlorentin 
7 8.480 261.2 C15H14O6 176.1(0), 55.2(28) Catechin 
8 9.790 359.1 C18H16O8 123.0 (20), 161.0 
(100) 
Rosmarinic acid 
9 13.81 313.1 C17H14O6 283.0 (32), 298.1 
(24) 
Cirsimaritin 
10 13.92 345.2 C20H26O5 283.2 (100), 301.2 
(49) 
Rosmanol 
11 15.14 283.1 C16H12O5 268.0 (100.0) Genkwanin 
12 15.57 150.1 C40H80NO8P 65.1(48), 65.1(44) Cephalin 
13 16.04 487.3 C30H48O5 -  Asiatic acid 
14 17.405 290.1 C15H10O7 168(16), 77(60) Quercetin 
15 18.558 208.1 C21H20O12 163.1 (8), 105.1 (24) Isoquercetin 
16 18.669 163.1 C21H24N2O3 130.1 (28) Latifoliamide 
17 18.746 208.1 C21H20O12 163.1 (8), 105.1 (24) Isoquercetin 
18 18.826 244.2 C21H20O9 91.1 (36), 86.2 (8) Diadzin 
19 21.91 471.3 C30H48O4 - Benthamic acid 
20 22.35 471.3 C30H48O4 - Augustic acid 
21 25.425 195.1 C14H6O8 83 (40) Ellargic acid 
22 29.116 147 C9H6O2 103.1 (20), 91.1 (20) Courmarin 
23 29.133 169 C7H6O5 125 (10), 79 (20) Gallic acid 
24 29.148 318.2 C21H24O10 196 (16), 82.1 (32) Phlorizin 
25 29.161 272.2 C21H20O12 215.1 (20), 171.1 
(40) 
Hyperin 
26 29.175 234.1 C27H32O14 84.1 (20) Naringin 
27 29.179 220.1 C28H34O15 84.1 (16) Hesperidin 
28 29.234 153 C7H6O4 109 (10), 108 (20) Gentisic acid 
29 29.384 177.1 C16H18O9 98.1 (24), 80.1 (28) Chlorogenic acid 
30 29.405 136.1 C29H40N2O4 119 (4), 91 (16) Emetine 
31 29.719 209.2 C17H23NO3 124.1 (24), 93.1 (32) Atropine 
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Peak Rt (s) m/z MF Fragments (CE) Compound 
32 30.25 455.4 C30H48O3 - Ursolic acid 
Rt: Retention time,  MF: Molecular formula, m/z-Mass to charge ratio, CE- Collision energy 
 
The rosemary extract contained 24 flavonoids 
(mainly flavones), 5 phenolic acids, 24 
diterpenoids (carnosic acid, carnosol, and 
rosmanol derivatives), 1 triterpenoid (betulinic 
acid) and 3 lignans (medioresinol derivatives). 
Carnosic acid was reported as the dominant 
phenolic compound in the extracts [60]. The 
compounds identified were Medioresinol, p-
Coumaric acid, Luteolin-rutinoside, Luteolin-
hexoside, Isorhamnetin-3-O-hexoside, 4-
hydroxybenzoic acid, Apigenin-7-O-glucoside, 
Homoplantaginin (Hispidulin 7-glucoside) 
among others which have been previously 
identified in this plant [38, 61-64]. Five phenolic 
acids (a hydroxybenzoic acid, two 
hydroxycinnamic acids and two rosmarinic acid 
derivatives) were identified, substantiating 















Figure 4. Structures of some molecules identified in R. 
officinalis leaves for the first time (a) procyanidin, 
hydroxyplorentin, (c) isoquercetin, (d) latifoliamide, (e) 
diadzin, (f) hyperin, and (g) emetine. 
Some of the compounds identified such as 
ursolic, rosmarinic and gallic acids were 
previously reported to have anticancer activity 
[36, 65]. Thus, the results of this study supports 
the traditional use of this plant in cancer therapy 












The results of this study showed that R. 
officinalis extracts has phenolic compounds with 
antiproliferative activity against human prostate 
(DU145), colorectal (CT26) and cervical (HeLa 
229) cancer cells. Selectivity of R. officinalis 
leaves in antiproliferative activity followed the 
order: solid phase extracted clean ups > ethyl 
acetate and methanolic fractions > crude extracts. 
Further studies should evaluate the anticancer 
activity of the extracts on other cancer cell lines 
because some of the polyphenols could be 
inactive on the cell lines investigated in this study 
yet active on the other cell lines that have not 
been studied. Studies on the anticancer potential 
of some of the identified unstudied compounds 
should be taken. The chemical composition and 
antiproliferative activity of R. officinalis roots 
should be done. 
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